CureVac N.V. (CVAC)
NASDAQ: CVAC · Real-Time Price · USD
3.190
0.00 (0.00%)
Apr 23, 2025, 4:00 PM EDT - Market closed
CureVac Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for CureVac stock have an average target of 10, with a low estimate of 4.00 and a high estimate of 16. The average target predicts an increase of 213.48% from the current stock price of 3.19.
Analyst Consensus: Buy
* Price targets were last updated on Feb 14, 2025.
Analyst Ratings
The average analyst rating for CureVac stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +401.57% | Feb 14, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $16 | Buy | Reiterates | $16 | +401.57% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $18 → $16 | Buy | Maintains | $18 → $16 | +401.57% | Aug 16, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $18 | Buy | Reiterates | $18 | +464.26% | Jul 3, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $12 → $4 | Buy → Hold | Downgrades | $12 → $4 | +25.39% | Apr 25, 2024 |
Financial Forecast
Revenue This Year
65.73M
from 535.18M
Decreased by -87.72%
Revenue Next Year
109.33M
from 65.73M
Increased by 66.34%
EPS This Year
-0.52
from 0.72
EPS Next Year
-0.29
from -0.52
Financial currency is EUR. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 162.8M | 158.6M | 223.0M | ||
| Avg | 65.7M | 109.3M | 216.6M | ||
| Low | n/a | 77.1M | 208.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -69.6% | 141.2% | 104.0% | ||
| Avg | -87.7% | 66.3% | 98.1% | ||
| Low | - | 17.3% | 90.4% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.12 | -0.13 |
| Avg | -0.52 | -0.29 |
| Low | -0.74 | -0.44 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.